This paper is in the following e-collection/theme issue:

Applications of AI (272) Generative Language Models Including ChatGPT (670) Natural Language Processing (893) Artificial Intelligence (2062) Chatbots and Conversational Agents (716) Substance Abuse (522) Machine Learning (2033)

Published on in Vol 4 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65481, first published .
AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and Validation

AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and Validation

AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and Validation

Authors of this article:

Benjamin Ogorek1 Author Orcid Image ;   Thomas Rhoads1 Author Orcid Image ;   Eric Finkelman1 Author Orcid Image ;   Isaac R Rodriguez-Chavez1, 2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Benjamin Ogorek   1 , PhD ;   Thomas Rhoads   1 , MBA ;   Eric Finkelman   1 , BS, MS ;   Isaac R Rodriguez-Chavez   1, 2 , MS, MHS, PhD

1 Spencer Health Solutions, Inc, Morrisville, NC, United States

2 4Biosolutions Consulting, Rockville, MD, United States

Corresponding Author:

  • Benjamin Ogorek, PhD
  • Spencer Health Solutions, Inc
  • 2501 Aerial Center Pkwy, Ste 100
  • Morrisville, NC 27560
  • United States
  • Phone: 1 866-971-8564
  • Email: baogorek@gmail.com